<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The plasma <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> are a group of macromolecules <z:hpo ids='HP_0000001'>all</z:hpo> of which transport <z:chebi fb="23" ids="18059">lipids</z:chebi>, including cholesterol, <z:chebi fb="0" ids="17855">triglyceride</z:chebi> and <z:chebi fb="0" ids="16247">phospholipid</z:chebi>, and <z:hpo ids='HP_0000001'>all</z:hpo> of which have one or more protein constituents, called <z:chebi fb="0" ids="13850">apoproteins</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>It is becoming apparent that the <z:chebi fb="0" ids="13850">apoproteins</z:chebi> play an important role in <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism </plain></SENT>
<SENT sid="2" pm="."><plain>Recently the so called "alpha hypothesis" has been proposed, according to which a protective role for <z:chebi fb="17" ids="39025">HDL</z:chebi> in <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> has been postulated </plain></SENT>
<SENT sid="3" pm="."><plain>Three "experiments of nature", characterized by deficiencies of <z:chebi fb="17" ids="39025">HDL</z:chebi> as <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorders</z:e>, namely <z:e sem="disease" ids="C0039292" disease_type="Disease or Syndrome" abbrv="HDLDT1">Tangier disease</z:e>, <z:e sem="disease" ids="C1704429" disease_type="Disease or Syndrome" abbrv="FHA|HDLC|HDLD">familial hypoalphalipoproteinemia</z:e>, familial lecithin: cholesterol acetyltransferase deficiency, support the "alpha hypothesis" </plain></SENT>
<SENT sid="4" pm="."><plain>The first italian cases with the <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorders</z:e> are presented </plain></SENT>
</text></document>